Journal of Clinical Oncology

The Journal of Clinical Oncology (JCO) is a medical journal published 3 times a month (36 issues a year) by the American Society of Clinical Oncology (ASCO), with a 2010 impact factor of 18.970. JCO now accounts for nearly one in 10 of all oncology journal citations. This journal s focus is work that relates to the care of patients with cancer, e.g., clinical oncology. This journal publishes in varying formats. Original research reports are both a communication tool and reports for original research. Review articles can describe work that builds on previous original research, summarize the current state clinical oncology, or can be a point of critical analysis. Opinion is voiced in editorial formats, which include commentary and discuss controversies. There is also a format for perspectives from a person of public notoriety. Special articles are another form of communication besides original research reports, which promulgate guidelines, summaries of consensus, and other scholarly communications. Fundamental research is covered in the "Biology of Neoplasia" section.

Publisher
American Society of Clinical Oncology
Impact factor
18.372 (2011)
Some content from Wikipedia, licensed under CC BY-SA

ASCO endorses ACS guideline for prostate CA survivor care

(HealthDay)—The American Society of Clinical Oncology (ASCO) has endorsed the American Cancer Society (ACS) Prostate Cancer Survivorship Care Guidelines, according to a report published online Feb. 9 in the Journal of Clinical ...

Feb 13, 2015
popularity13 comments 0

Mammography rates down since 2009 USPSTF guidelines

(HealthDay)—Since the publication of the U.S. Preventive Services Task Force guidelines for mammography in 2009, there has been a decrease in mammography rates among white, Hispanic, and Asian women, according to a study ...

Feb 12, 2015
popularity4 comments 0

The future of precision immunology

In his State of the Union address, President Obama announced a new precision medicine initiative to work on finding a cure for cancer and other diseases. Howard L. Kaufman, a leading immunotherapy expert from Rutgers Cancer ...

Jan 30, 2015
popularity22 comments 0